ivWatch Announces Compatibility with Philips IntelliVue Patient Monitors

ivWatch, FDA Cleared IV site monitor, supports Philips IntelliVue Patient Monitors for in-room and remote notifications and electronic medical record (EMR) data capture.

HAMPTON, Va., June 21, 2018 – ivWatch, the only provider of continuous non-invasive monitoring devices for the early detection of peripheral intravenous (IV) infiltrations and extravasations, now supports Philips IntelliVue Patient Monitors for in-room and remote notifications and electronic medical record (EMR) data capture.

“Interoperability with an industry leader like Philips enables IV infiltration notifications and IV assessment data to be more widely available to health care providers,” said Gary Warren, president and CEO of ivWatch.

Already an FDA-cleared standalone device that can be integrated with any infusion pump or IV gravity infusion, the ivWatch Model 400 provides infiltration notifications through the Philips IntelliBridge EC10 Interface Module or IntelliBridge EC10 integral Interface Board with Open Interface Driver (ED101) and EC5 ID Module on MP40-90 and MX400-800 Philips patient monitors.

ivWatch visual notifications informing clinicians of infiltration events can be displayed on a designated Philips patient monitor, as well as generated on remote nursing station monitors allowing care providers to respond quickly. Early detection of these complications helps minimize harm. In addition, a clinician is able to document the overall state/health of the IV or if there was an infiltration directly from the Model 400 user interface during a patient assessment. Integration with Philips technology enables health care facilities to leverage their current infrastructure and capture the IV assessment data in their existing EMR systems.

“Our vision is to eliminate harm associated with IV infiltrations and extravasations,” said Warren. “We will continue to work with like-minded companies to make this technology solution available to as many health care organizations as possible as we embark on a new IV therapy standard of care.”

To learn more about ivWatch and the Model 400, visit ivwatch.com.

About ivWatch:
ivWatch, LLC is the leading medical device manufacturer and biosensor technology company focused on improving patient safety and the effectiveness of intravenous therapy. Our dedicated and passionate team is focused on our company vision of eliminating patient harm caused by infiltrations and extravasations. Through our innovative monitored IV solutions, we help minimize the risks associated with adverse IV events. Follow us on Twitter @ivWatch or Facebook @ivWatchLLChttps://www.ivwatch.com/


Erin Wendell


Mobile (757) 633-4688